SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Casterlin Douglas

(Last)

(First)

(Middle)

C/O MELISSA A. WATERHOUSE/ABMC

122 SMITH ROAD

(Street)

KINDERHOOK

12106

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/28/2008

3. Issuer Name and Ticker or Trading Symbol
AMERICAN BIO MEDICA CORP [ ABMC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	114,500	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Non-Statutory Stock Option⁽¹⁾	11/04/1998⁽²⁾	11/22/2009	Common Shares	100,000	$2.5	D
Non-Statutory Stock Option⁽³⁾	05/02/2000⁽⁴⁾	05/02/2010	Common Shares	150,000	$2	D
Non-Statutory Stock Option⁽⁵⁾	01/10/2002⁽⁶⁾	01/10/2011	Common Shares	50,000	$0.94	D

Explanation of Responses:

1. Prior to his re-appointment to Executive Vice President effective April 28, 2008, Mr. Casterlin served as the Company's Executive Vice President from May 1997 to January 2004. This option grant was issued to Mr. Casterlin on 11/22/99 during his previous employment with the Company, and Mr. Casterlin was allowed to keep the option as if his departure had not occured.

2. The option grant vested 25% each year on the anniversary of 11/4/1998. The option grant vested in full on 11/4/2002.

3. Prior to his re-appointment as Executive Vice President effective April 28, 2008, Mr. Casterlin served as the Company's Executive Vice President from May 1997 until January 2004. This option was granted to Mr Casterlin on 5/2/2000 during his previous employment with the Company and Mr. Casterlin was allowed to keep th option as if such departure had not occured.

4. Option grant was 100% exercisable on the date of the grant

5. Prior to his re-appointment as Executive Vice President effective April 28, 2008, Mr. Casterlin served as the Company's Executive Vice President from May 1997 until January 2004. This option grant was issued to Mr. Casterlin on 10/02/01 during his previous employment with the Company and Mr. Casterlin was allowed to keep the option as if such departure had not occured.

6. Option grant vested over 4 years in 25% increments beginning January 10, 2002 and were fully vested on January 10, 2005.

	Douglas Casterlin	05/07/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.